Basdai Calculator - AS Disease Activity Score

The basdai score is a validated 0 to 10 index used by rheumatology teams to track disease activity in ankylosing spondylitis, the chronic inflammatory arthritis that most often affects the spine and sacroiliac joints. Developed in 1994 by a research team in Bath, England, it is now a standard part of AS assessment, biologic therapy reviews, and clinical research. This tool adds six 0 to 10 ratings, averages the two morning-stiffness items, and labels the 0 to 10 total with the published suboptimal-control threshold of 4.

• • Self-check between rheumatology visits: an adult with a confirmed AS diagnosis can record a structured 0 to 10 score before a scheduled visit.
• • Treatment response review: a patient on an NSAID, conventional disease-modifying antirheumatic drug, or biologic can repeat the score after a treatment change to see whether the result has moved away from the 4-point band.
• • Caregiver support for a family member: a partner or adult child can help a person with AS capture the same six ratings when morning stiffness makes a clinic-day form harder.
• • Screening before a first rheumatology referral: a primary care clinician can use the same six items to record a baseline before referring a patient to a rheumatology team.

The index sits in the same family of validated rheumatology scores as the Bath Ankylosing Spondylitis Functional Index and the Bath Ankylosing Spondylitis Metrology Index. The diagnosis of ankylosing spondylitis still depends on clinical review, imaging, and laboratory findings.

Both scores turn a few clinical items into a single validated number, and the Aleve Dosage Calculator applies the same idea to naproxen sodium dosing, the first-line NSAID for ankylosing spondylitis before biologics.

The score is calculated by adding four core symptom ratings and one averaged morning-stiffness rating, then dividing the result by five to keep the total on the published 0 to 10 scale. The two morning-stiffness items are averaged because they describe the same symptom from a severity and a duration angle.

• q1: fatigue or overall tiredness over the past week on a 0 to 10 scale.
• q2: AS-related neck, back, or hip pain over the past week on a 0 to 10 scale.
• q3: pain or swelling in other joints over the past week on a 0 to 10 scale.
• q4: discomfort from any areas tender to touch or pressure over the past week on a 0 to 10 scale.
• q5: level of morning stiffness on waking over the past week on a 0 to 10 scale.
• q6: duration of morning stiffness over the past week, where 0 is none and 10 is two hours or more.

Each rating is rounded to a whole number, and out-of-range or blank entries are clamped to 0 or 10 so the total never leaves the published range. The form keeps both morning-stiffness items visible so a user can see whether stiffness, duration, or both are driving the result.

According to Garrett et al., The Journal of Rheumatology, 1994, the index uses six 0 to 10 items, averages the two morning-stiffness items, and divides the total by five, with a score of 4 or more signaling suboptimal control of ankylosing spondylitis.

The same patient often reviews NSAID use alongside a basdai reading, and the Ibuprofen Dosage Calculator helps that person check over-the-counter dose limits between visits without replacing a clinician review.

Four ideas drive the result. Naming them keeps the score from being read as a single number without context.

The reading is shared between patient and clinician, which is why the form is built to be filled out at home, in a waiting room, or at the start of a telehealth visit.

Sleep debt is an under-recognized driver of the Q5 and Q6 morning-stiffness ratings, and the Sleep Debt Calculator helps the same patient see the weekly shortfall that often travels with active ankylosing spondylitis.

The form works from six 0 to 10 ratings, with the two morning-stiffness items averaged into one weight in the published formula. The order below mirrors a typical AS self-check.

1. 1 Pick a representative past week: use the past seven days, not a single best or worst day.
2. 2 Rate the four core symptoms first: enter 0 to 10 for fatigue, AS neck back or hip pain, joint pain or swelling, and tender-area discomfort.
3. 3 Rate the two morning-stiffness items: enter 0 to 10 for stiffness level on waking, and 0 to 10 for stiffness duration.
4. 4 Press Calculate and read the total: the form returns the 0 to 10 score, the averaged morning-stiffness value, the activity band, the suboptimal-control flag, and the highest single item.
5. 5 Save the score with the date and context: record the date, current treatment, and any recent flare or missed dose so the next reading can be compared with the same context.
6. 6 Share the score with a rheumatology clinician: bring the saved total to a rheumatology visit, biologic review, or telehealth follow-up so the team can compare readings on the same scale.

A person with stable AS rates the six items as 1, 2, 1, 1, 2, 1 for a score of 1.30, which sits in the optimal-control band. Six weeks after a treatment change, the same items move to 4, 5, 4, 4, 5, 4 for a total of 4.30, which crosses the 4-point threshold and is a clear prompt to bring both readings to the next visit.

A treatment review triggered by a high basdai often includes a kidney-function check, and the GFR Calculator helps the same patient estimate glomerular filtration rate between blood tests.

Using the form in a structured way offers several practical advantages for people living with AS and the rheumatology teams who support them.

• • A validated 0 to 10 activity score: turns a vague impression of recent AS activity into a single published number that rheumatology teams understand.
• • Quick enough for repeat tracking: the six items can be completed in about 30 seconds to two minutes, so the form can be used before every scheduled visit.
• • Built-in suboptimal-control flag: the 4 or higher flag matches the published Garrett et al. threshold.
• • Visible morning-stiffness average: the form shows the averaged (Q5 + Q6) / 2 result.
• • Shared language with a rheumatology team: the same six items, scale, and 0 to 10 total are used in adult rheumatology clinics.
• • Reusable baseline and follow-up scores: the form can be filled in again after a treatment change or stable period.

A single reading captures one recent week, while a series of readings shows the direction of AS activity and the impact of treatment changes over time.

Body mass index is one of the body-composition labels rheumatology teams look at alongside the basdai, and the BMI Calculator gives the same patient a single number to bring into a review.

The score depends on the six ratings entered and on the recent routine behind them. A few everyday factors can move a reading without changing the underlying disease.

• • The index is a screening and tracking tool, not a diagnostic test. A persistently high score deserves a clinical evaluation with blood markers, imaging, and a clinician exam.
• • The form uses a patient-reported 0 to 10 scale. A patient who rates their symptoms low because of habit or stoicism can still have active disease.
• • The two morning-stiffness items are averaged into one weight, so a high severity with a short duration and a low severity with a long duration can produce the same averaged value. The form keeps both raw ratings visible.

A reading of 4 or more is the published prompt to discuss a treatment review, and a score of 7 or more is often the band used to escalate therapy or screen for biologic and clinical-trial enrolment.

According to NHS Ankylosing Spondylitis, ankylosing spondylitis is a long-term inflammatory condition that usually starts in young adults, has no cure, and is monitored with validated scores like this one alongside treatment reviews, exercise, and physiotherapy.

According to the Spondylitis Association of America, ankylosing spondylitis is a chronic inflammatory arthritis that usually starts in young adults, has no cure, and is monitored with validated scores like the basdai alongside treatment reviews, exercise, and physical therapy.

For a patient whose basdai stays high despite NSAIDs, rheumatology teams often consider adding a conventional DMARD for peripheral joint pain, and the Hydroxychloroquine Dose Calculator applies the weight-based retinal-safety ceiling to that conversation.